Ms. Amick has been pivotal in Aspirion’s trajectory since stepping into the role of CEO. Within her first year, she has driven the company to over 30% organic growth and championed an aggressive mergers and acquisitions strategy, solidifying its position as a leader in the denials management market. Her commitment to client excellence, AI-driven innovation and scalability has driven substantial organic growth and the successful integration of three strategic acquisitions, significantly enhancing revenue recovery for provider partners and fostering sustained success and growth. These accomplishments reflect Ms. Amick’s deep commitment to restoring financial stability for hospitals still grappling with the effects of the Covid-19 pandemic. Her leadership and strategic vision have also earned the company the Best in KLAS Denials Management Award. Prior to Aspirion, Ms. Amick held leadership roles including CEO and president at SPH Analytics, president of revenue cycle at MedAssets, COO at MedQuist/M*Modal, general manager at Microsoft Health Solutions Group and senior vice president at Mysis/Allscripts.
